top
Search terms
Results 1 - 10 of 44 - ordered by :
Pages: 1 2 3 4 5 ... 5
Ejhf

Introduction Heart failure (HF) is the second most important risk factor for severe ischaemic stroke after atrial fibrillation (AF).1 HF predisposes to stroke in a multifactorial manner, including ...

European Journal of Heart Failure, Vemmos, Kostas, Ntaios, George, Savvari, Paraskevi, Vemmou, Anastasia M., Koroboki, Eleni, Manios, Efstathios, Kounali, Anna, Lip, Gregory Y.H.

Date : 01/02/2012 Item size : 173293 bytes
Ejhf

Normal systolic blood pressure and risk of heart failure in US male physicians Tel: +1 857 364 6119, Fax: +1 857 364 4424, Email: kfinnerty@post.harvard.edu Search for more papers by this author J. ...

European Journal of Heart Failure, Britton, Kathryn A., Gaziano, J. Michael, Djoussé, Luc

Date : 01/12/2009 Item size : 133949 bytes
Ejhf

Predictors of fatal and non‐fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A‐1, high‐sensitivity C‐reactive ...

European Journal of Heart Failure, Wedel, Hans, McMurray, John J.V., Lindberg, Magnus, Wikstrand, John, Cleland, John G.F., Cornel, Jan H., Dunselman, Peter, Hjalmarson, Åke, Kjekshus, John, ...

Date : 01/03/2009 Item size : 233317 bytes
Epeuropace

Abstract Aims Serum uric acid (SUA) has been associated with cardiovascular disease in population studies, but its relation to atrial fibrillation (AF) is largely unknown. Information on angina, ...

Europace, Atrial fibrillation, Audhild Nyrnes, Ingrid Toft, Inger Njølstad, Ellisiv B. Mathiesen, Tom Wilsgaard, John-Bjarne Hansen, Maja-Lisa Løchen

Date : 01/03/2014 Item size : 275770 bytes
Epeuropace

Methods and results The PROspective Study of Pravastatin in the Elderly at Risk (PROSPER) was a randomized, double-blind controlled trial that recruited 5804 individuals aged 7082 years with a ...

Europace, Atrial Fibrillation, Peter W. Macfarlane, Heather Murray, Naveed Sattar, David J. Stott, Ian Ford, Brendan Buckley, J. Wouter Jukema, Rudi G.J. Westendorp, James Shepherd

Date : 01/05/2011 Item size : 229229 bytes
Epeuropace

Methods and results Between January 2005 and December 2007 individuals aged 50 years, residents of the city of Geneva, who had participated in a previous random survey were invited for follow-up ...

Europace, CLINICAL RESEARCH, Mathieu Schmutz, Sigrid Beer-Borst, Alexandre Meiltz, Philip Urban, Jean-Michel Gaspoz, Michael C. Costanza, Alfredo Morabia, Marc Zimmermann

Date : 01/04/2010 Item size : 249333 bytes
Ehjournal

Introduction Sudden cardiac death (SCD) forms a substantial part of cardiovascular mortality, which is the leading cause of death globally,1 with a currently estimated incidence of 45 million cases ...

European Heart Journal, Prevention and epidemiology, Lies Lahousse, Maartje N. Niemeijer, Marten E. van den Berg, Peter R. Rijnbeek, Guy F. Joos, Albert Hofman, Oscar H. Franco, Jaap W. Deckers, Mark ...

Date : 14/07/2015
Ehjournal

Disease association is not conclusive, because data providing functional effects are missing. [...]the majority of SNP are located in intergenic regions of the human genome. For a long time, these ...

European Heart Journal, Editorial, Birgit Stallmeyer, Eric Schulze-Bahr

Date : 07/07/2015
Epeuropace

Methods and results The INTRINSIC RV study enrolled 1530 new ICD recipients who were not in permanent atrial fibrillation who received a VITALITY AVT (Guidant, St Paul, MN, USA) standard energy (31 J ...

Europace, ICDS, John D. Day, Brian Olshansky, Stephen Moore, Scott Brown, Kira Q. Stolen, Darin R. Lerew

Date : 01/03/2008
Ehjcardiovascrec

Abstract Cardiac societies recommend the intake of 1 g/day of the two omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) for cardiovascular disease prevention, ...

Cardiovascular Research, Review, Clemens von Schacky, William S. Harris

Date : 15/01/2007